Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listPamidronate disodium salt

Pamidronate disodium salt

Synonym(s):3-Amino-1-hydroxy-1-phosphonopropanephosphonic acid disodium salt hydrate

  • CAS NO.:57248-88-1
  • Empirical Formula: C3H12NNaO7P2
  • Molecular Weight: 259.07
  • MDL number: MFCD01938386
  • EINECS: 260-647-1
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-06 15:28:16
Pamidronate disodium salt Structural

What is Pamidronate disodium salt?

Description

Disodium pamidronate is a calcium metabolism regulator useful in the treatment of hypercalcemia associated with malignancy. It presumably reduces the bone resorption of calcium by inhibiting the formation and attachment of osteoclasts. Other potential uses include osteoporosis and calcitonin-resistant Paget’s disease.

Chemical properties

White Crystals

Originator

Henkel (United Kingdom)

The Uses of Pamidronate disodium salt

A bisphosphonate antiresorptive agent; bone resorption inhibitor.

The Uses of Pamidronate disodium salt

Pamidronate disodium is a nitrogen containing bisphosphonate, used to prevent osteoporosis. It is used to prevent bone loss, and treat osteoporosis.

The Uses of Pamidronate disodium salt

A farnesyl diphosphate synthase inhibitor

What are the applications of Application

Pamidronate disodium salt is a farnesyl diphosphate synthase inhibitor

Manufacturing Process

For a batch size of 5 L, 587.5 g (3.2 moles) of mannitol is dissolved in 3.5 L of water. Pamidronic acid (31.6 g, 0.133 moles) is mixed with a 1.0 L aliquot of the mannitol solution to form a slurry. The slurry is then transferred into the remainder of the mannitol solution, and stirred for at least 15 min. Aqueous 1 N sodium hydroxide (270 ml) is then added and the mixture is stirred until a clear, colorless solution results. The pH is then adjusted to 6.50.1 using either 1 M aqueous phosphoric acid or 1 N aqueous sodium hydroxide, as needed. The solution is then filtered through a 0.22 micron filter, and filled at 20°C into vials at 4.0 ml (4.172 g)/vial, under sterile conditions. The aqueous solution is frozen at -37°C and lyophilized (20 mbar, 20°-40°C) to yield 1,250 vials, each containing 30 mg of amorphous disodium pamidronate. The vials are sealed under positive nitrogen pressure. The disodium pamidronate is amorphous (noncrystalline) by X-ray diffraction and contains 0.7 wt-% water.

brand name

Aredia (Novartis).

Therapeutic Function

Bone resorption suppressant

Biochem/physiol Actions

Pamidronate disodium?has the ability to block Wnt and β-catenin signaling, which modulates the osteogenic differentiation in bone marrow mesenchymal stem cells (BMMSCs). It can also reduce bilirubin-impaired apoptosis and helps to develop dentinogenic dysfunction of stem cells from human deciduous teeth.

Veterinary Drugs and Treatments

Pamidronate may be useful in treating hypercalcemia associated with vitamin D-related toxicoses or hypercalcemia of malignancy. There is ongoing research on the use of this drug to determine if it has clinical usefulness in directly treating “micro-metastases” in osteosarcomas.

Properties of Pamidronate disodium salt

Melting point: 300 °C
storage temp.  2-8°C
solubility  H2O: 28 mg/mL
form  solid
color  white
Merck  14,7003
Stability: Hygroscopic
CAS DataBase Reference 57248-88-1(CAS DataBase Reference)

Safety information for Pamidronate disodium salt

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H302:Acute toxicity,oral
H319:Serious eye damage/eye irritation
Precautionary Statement Codes P264:Wash hands thoroughly after handling.
P264:Wash skin thouroughly after handling.
P270:Do not eat, drink or smoke when using this product.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P337+P313:IF eye irritation persists: Get medical advice/attention.

Computed Descriptors for Pamidronate disodium salt

Related products of tetrahydrofuran

You may like

  • 57248-88-1 98%
    57248-88-1 98%
    57248-88-1
    View Details
  • 57248-88-1 Pamidronate disodium 98%
    57248-88-1 Pamidronate disodium 98%
    57248-88-1
    View Details
  • Pamidronate disodium 97% CAS 57248-88-1
    Pamidronate disodium 97% CAS 57248-88-1
    57248-88-1
    View Details
  • Sodium (3-amino-1-hydroxy-1-phosphonopropyl)phosphonate hydrate 95% CAS 57248-88-1
    Sodium (3-amino-1-hydroxy-1-phosphonopropyl)phosphonate hydrate 95% CAS 57248-88-1
    57248-88-1
    View Details
  • Disodium pamidronate hydrate 95% CAS 57248-88-1
    Disodium pamidronate hydrate 95% CAS 57248-88-1
    57248-88-1
    View Details
  • Disodium Pamidronate CAS 57248-88-1
    Disodium Pamidronate CAS 57248-88-1
    57248-88-1
    View Details
  • Pamidronate disodium salt hydrate CAS 57248-88-1
    Pamidronate disodium salt hydrate CAS 57248-88-1
    57248-88-1
    View Details
  • Disodium pamidronate CAS 57248-88-1
    Disodium pamidronate CAS 57248-88-1
    57248-88-1
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.